Wim Jiskoot

5PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsEnvironmental studies in animal productionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Chemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 30, 2021
Cationic Nanoparticle-Based Cancer Vaccines.

Jeroen Heuts, Wim Jiskoot, Ferry Ossendorp

|Dec 19, 2020
Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics.

Laura M de Jong, Wim Jiskoot, Jesse J Swen

|Dec 04, 2020
Degradomics-Based Analysis of Tetanus Toxoids as a Quality Control Assay.

Thomas J M Michiels, Wichard Tilstra, Martin R J Hamzink

|Oct 16, 2020
Tc17 CD8+ T cells accumulate in murine atherosclerotic lesions, but do not contribute to early atherosclerosis development.

Janine van Duijn, Maaike J M de Jong, Naomi Benne

|Apr 25, 2020
Complement Receptor Targeted Liposomes Encapsulating the Liver X Receptor Agonist GW3965 Accumulate in and Stabilize Atherosclerotic Plaques.

Naomi Benne, Renata Martins Cardoso, Aimee L Boyle

Pageof 1

Frequent Collaborators

2 joint publications

Bram Slütter

1 joint publications

Renata Martins Cardoso

1 joint publications

Aimee L Boyle

1 joint publications

Alexander Kros